Nitric oxide and cancer: the emerging role of S-nitrosylation

E Aranda, C Lopez-Pedrera… - Current molecular …, 2012 - ingentaconnect.com
Nitric oxide (NO˙) is a short-lived, endogenously produced gas that is highly diffusible across
cell membranes and acts as a signaling molecule in the body. The redox state and chemistry …

Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines

R Tandon, I Singh, V Luxami, N Tandon… - The Chemical …, 2019 - Wiley Online Library
Besides worthy development in cancer therapy, cancer is still one of the leading causes of
death, worldwide. The future burden of cancer will probably be even larger because people …

The importance of cancer cell lines as in vitro models in cancer methylome analysis and anticancer drugs testing

D Ferreira, F Adega, R Chaves - Oncogenomics and cancer …, 2013 - books.google.com
Cancer is a molecularly heterogeneous disease [1] and one of the major causes of death
worldwide. The existence of various types of tumours with different histopathologies, genetic …

Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin

N Hulsman, JP Medema, C Bos… - Journal of medicinal …, 2007 - ACS Publications
Hybrid drug 1 (NO-ASA) continues to attract intense research from chemists and biologists
alike. It consists of ASA and a− ONO2 group connected through a spacer and is in …

Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells

J Xie, BS Wang, DH Yu, Q Lu, J Ma… - International …, 2011 - spandidos-publications.com
The unique bioenergetic feature of cancer, aerobic glycolysis or the Warburg effect, is an
attractive therapeutic target for cancer therapy. Reversing the glycolytic phenotype may …

Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo

M Rahman, K Selvarajan, MR Hasan, AP Chan, C Jin… - Neoplasia, 2012 - Elsevier
Abstract Higher cyclooxygenase 2 (COX-2) expression is often observed in aggressive
colorectal cancers (CRCs). Here, we attempt to examine the association between COX-2 …

Anti-inflammatory agents as cancer therapeutics

K Kashfi - Advances in pharmacology, 2009 - Elsevier
Cancer prevention sometimes referred to as tertiary prevention or chemoprevention makes
use of specific xenobiotics or drugs to prevent, delay, or retard the development of cancer …

Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy

D Hirst, T Robson - Current pharmaceutical design, 2010 - ingentaconnect.com
Nitric oxide is a key second messenger in most tissues, where it is generated at low
concentrations, predominantly by the catalytic action of two constitutively expressed isoforms …

Camphor and menthol as anticancer agents: Synthesis, structure-activity relationship and interaction with cancer cell lines

H Singh, R Kumar, A Mazumder… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Cancer is a type of human cell degenerative disease that has afflicted a large number of
people for years. Cancer is caused due to the abnormal proliferation of cells in any part of …

The dichotomous role of H2S in cancer cell biology? Deja vu all over again

K Kashfi - Biochemical pharmacology, 2018 - Elsevier
Nitric oxide (NO) a gaseous free radical is one of the ten smallest molecules found in nature,
while hydrogen sulfide (H 2 S) is a gas that bears the pungent smell of rotten eggs. Both are …